Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case report

• Peter G. Rose

Affiliations

Peter G. Rose

Section of Gynecologic Oncology, Women's Health Institute, Cleveland Clinic, A-81, 9500 Euclid Ave., Cleveland, OH 44195, USA